## Abstract ## __Background.__ Despite diagnostic and therapeutic advances in head and neck cancer, the 5‐year survival of patients with laryngeal cancer has not improved in the last 30 years. Several recent studies indicate that specific targets for immunotherapeutic approaches can be useful in t
Expression of mage-A4 and mage-C1 tumor-associated antigen in benign and malignant thyroid diseases
✍ Scribed by Daniel Hardy Melo; Rui Celso Martins Mamede; Luciano Neder; Fabiano Pinto Saggioro; David Livingstone Alves Figueiredo; Wilson Araújo da Silva Jr; Achim A. Jungbluth; Marco Antônio Zago
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 472 KB
- Volume
- 33
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background
A subset of thyroid tumors characterized by a follicular growth pattern can represent a serious diagnosis. Immunohistochemistry and molecular pathology for genetic profiling have been used in an attempt to resolve some of these issues.
Methods
Tumor tissue samples of thyroid were obtained from 70 patients who underwent surgical therapy. They were divided into 4 groups: 20 adenomatous goiters, 10 follicular adenomas, 24 papillary carcinomas, and 16 follicular carcinomas. Immunohistochemical analysis was carried out using antibodies for MAGE‐A4 (melanoma antigen‐encoding gene A4) and MAGE‐C1 (melanoma antigen‐encoding gene C1).
Results
Standard histologic analysis and immunohistochemistry analysis of MAGE‐A4 and MAGE‐C1 expression were performed in all patients. The antigens examined were not expressed in any of the tissues.
Conclusions
The malignant degeneration of normal tissues is a multifactorial process, varying considerably both among tumor types and among individual patients. The present study showed that there was no immunolabeling of the MAGE‐A4 and MAGE‐C1 antigens. © 2011 Wiley Periodicals, Inc. Head Neck, 2011
📜 SIMILAR VOLUMES
The purpose of our study was to determine the expression of the pro-apoptotic BAX protein in relation to the mutational status of BAX and p53 (as transcriptional activator of the BAX gene) in benign and malignant thyroid tissue. In 47 patients with thyroid tumours (14 follicular and 3 papillary carc
## Abstract Previous studies indicate that the nonclassical class I HLA‐G antigen, whose physiologic expression is mainly restricted to placenta, is upregulated in melanoma, renal carcinoma, lung carcinoma, glioblastoma and ovarian carcinoma, where its inhibitory effect on cytotoxic effector cells
## Abstract Rhabdomyosarcoma (RMS), the most common pediatric soft tissue sarcoma likely results from abnormal proliferation and differentiation during skeletal myogenesis. Multiple genetic alterations are associated with the three RMS histopathological subtypes, embryonal, alveolar, and pleomorphi
Human melanoma cells express several antigens which are recognized by autologous and specific CTL clones in association with HLA-class-I molecules. Many of these antigens represent suitable targets for tumor immunotherapy, since their expression in human melanoma cells is common and highly specific.
## Abstract Routine pathological examination cannot distinctively predict the clinical course of meningiomas because even histologically benign tumors may recur after gross total resection. Numerous efforts have been made for the evaluation of different immunohistochemical assays in meningioma prog